ADW Capital Urges Driven Brands to Explore Sale
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 25 2026
0mins
Should l Buy DRVN?
ADW Capital pushes Driven Brands to explore sale, WSJ reports
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DRVN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DRVN
Wall Street analysts forecast DRVN stock price to rise
8 Analyst Rating
7 Buy
1 Hold
0 Sell
Strong Buy
Current: 12.780
Low
17.00
Averages
21.14
High
24.00
Current: 12.780
Low
17.00
Averages
21.14
High
24.00
About DRVN
Driven Brands Holdings Inc. is an automotive services company in North America, providing a range of consumer and commercial automotive services, including paint, collision, glass, vehicle repair, oil change and maintenance. The Company's segments include Take 5 and Franchise Brands. The Take 5 segment is primarily composed of the Company and franchise-operated Take 5 Oil Change business. The Franchise Brands segment is primarily composed of its portfolio of franchise brands, which include CARSTAR, Meineke Car Care Centers, Maaco and 1-800-Radiator & A/C, along with other smaller brands and services for both retail and commercial customers such as commercial fleet operators and insurance carriers. Its AutoGlassNow businesses provide glass replacement and calibration services to commercial, retail and insurance customers. Its subsidiaries include All Star Glass, LLC, AGN Glass, LLC, Carstar Canada GP Corp, Boing US Holdco, Inc, and others.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Class Action Notice: Rosen Law Firm reminds investors who purchased Driven Brands stock between May 3, 2023, and February 24, 2026, to apply as lead plaintiffs by May 8, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Driven Brands had significant weaknesses in its internal controls over financial reporting, resulting in material errors in its financial statements for fiscal years 2023 and 2024, undermining investor confidence in the company's business and prospects.
- Law Firm's Credentials: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, demonstrating its extensive experience and successful track record in handling such cases.
- Investor Action Recommendations: Investors can visit the Rosen Law Firm website or call the toll-free number for more information, emphasizing the importance of selecting qualified legal counsel to protect their rights and avoid inexperienced intermediaries.
See More
- Lawsuit Expansion: Hagens Berman has filed a securities class action lawsuit against Driven Brands and its executives, covering investors from May 3, 2023, to February 24, 2026, highlighting severe deficiencies in the company's financial transparency.
- Stock Price Plunge: Following the company's admission of significant errors in its financial statements, Driven Brands' stock price plummeted by $5.61 (-33%) over three trading days ending February 27, 2026, resulting in a loss of over $900 million in market capitalization and directly impacting investor confidence.
- Financial Restatement: On February 25, 2026, Driven Brands acknowledged that its financial statements were no longer reliable and would be restated, revealing inadequate effectiveness of internal controls, which exacerbated market concerns regarding its financial health.
- Investor Action: Hagens Berman encourages investors with substantial losses to submit their claims before the May 8, 2026, Lead Plaintiff Deadline, reflecting a strong emphasis on corporate governance and financial compliance.
See More
- Lawsuit Deadline: ClaimsFiler reminds investors that those who purchased Driven Brands shares between May 3, 2023, and February 24, 2026, must file lead plaintiff applications by May 8, 2026, to secure their rights in the upcoming class action lawsuits.
- Financial Restatement: On February 25, 2026, Driven Brands disclosed the identification of at least seven categories of 'material errors' in its consolidated financial statements for fiscal years 2023 and 2024, indicating that these statements should not be relied upon and necessitating a restatement, which delays the filing of its 2025 Annual Report.
- Stock Price Plunge: Following the announcement of the financial restatement, Driven Brands' stock price plummeted nearly 40%, dropping from a closing price of $16.61 on February 24, 2026, to an opening price of $9.99 on February 25, 2026, reflecting severe market concerns regarding the company's financial transparency.
- Legal Liability Risks: The company and its executives face allegations of violating federal securities laws for failing to disclose material information during the class period, which could lead to further legal and financial repercussions, impacting the company's future operations and investor confidence.
See More
- Class Action Initiation: A shareholder has filed a securities class action lawsuit against Driven Brands Holdings Inc. on behalf of investors who purchased shares between May 9, 2023, and February 24, 2026, alleging that the company made misrepresentations about its financial condition during this period, potentially leading to investor losses.
- Lawsuit Details: Investors wishing to participate in the lawsuit must file papers by May 8, 2026, to serve as lead plaintiff, representing other shareholders, although those who do not wish to take on this role can still share in any recovery.
- Legal Fee Structure: All representation is on a contingency fee basis, meaning shareholders incur no fees or expenses, which reduces the financial burden on investors and encourages more affected shareholders to join the action.
- Law Firm Background: Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has been recognized multiple times for its success in litigating class actions, demonstrating its expertise and credibility in the securities litigation field.
See More
- Class Action Initiation: Driven Brands Holdings Inc. is facing a class action lawsuit due to financial reporting errors from May 3, 2023, to February 24, 2026, with investors having until May 8, 2026, to seek lead plaintiff status, indicating a significant increase in legal risks for the company.
- Financial Misstatement Disclosure: On February 25, 2026, the company revealed that its Audit Committee found material errors in its financial statements for fiscal year 2024, leading to a nearly 40% drop in stock price, which not only undermines investor confidence but may also result in future financial restatements and increased compliance costs.
- Scope of Errors: The lawsuit alleges errors in the recording of right-of-use assets and liabilities on the balance sheet, as well as overstatements of cash and revenue for fiscal years 2023 and 2024, which could damage the company's reputation in the market and affect its ability to raise capital.
- Potential Legal Consequences: Robbins Geller Rudman & Dowd LLP, as the representing law firm, highlights investors' heightened concern over corporate governance and financial transparency, potentially leading to more legal actions and regulatory scrutiny, thereby increasing operational uncertainties for the company.
See More
- Eos Energy Lawsuit: Eos Energy Enterprises is facing allegations for failing to meet production and capacity utilization targets from November 2025 to February 2026, which could severely undermine investor confidence and negatively impact its stock performance.
- Soleno Therapeutics Risks: Soleno Therapeutics is accused of concealing safety concerns in its DCCR clinical trials, potentially exposing patients to greater risks, which may adversely affect product acceptance and commercial viability, leading to potential investor losses.
- Nektar Therapeutics Trial Issues: Nektar Therapeutics is under scrutiny for not adhering to applicable standards in its REZOLVE-AA trial, which could compromise the integrity of trial results and affect future R&D and market strategies, creating uncertainty for shareholders.
- Driven Brands Financial Errors: Driven Brands is accused of financial reporting errors from 2023 to 2026, resulting in misstatements of cash flows and revenues, which could negatively impact its financial health and investor confidence.
See More











